Veradermics, Incorporated (MANE) — Financial Flexibility Index
Veradermics, Incorporated (MANE) has a Financial Flexibility Index of -3.15x as of March 2026. Free cash flow of $-21.17 Million (operating CF $-21.17 Million minus capex $0.00) represents -3% of total liabilities ($6.72 Million). Check how resilient are Veradermics, Incorporated's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Veradermics, Incorporated Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Veradermics, Incorporated across 3 annual periods. See Veradermics, Incorporated working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Veradermics, Incorporated (2023–2025)
Year-by-year free cash flow to debt coverage for Veradermics, Incorporated. For the full company profile including market capitalisation, see Veradermics, Incorporated (MANE) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.26x | $-71.58 Million | $-71.60 Million | $273.63 Million | ▲ +94.8% |
| 2024 | -5.02x | $-23.69 Million | $-23.69 Million | $4.72 Million | ▼ -42.6% |
| 2023 | -3.52x | $-13.51 Million | $-13.51 Million | $3.84 Million | — |